Cargando…

Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction

The prevalence of gout and the adverse effects of current synthetic anti-gout drugs call for new natural and effective xanthine oxidase (XOD) inhibitors to target this disease. Based on our previous finding that an edible seaweed Pterocladiella capillacea extract inhibits XOD, XOD-inhibitory and ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yawen, Zhou, Longjian, Chen, Minqi, Liu, Yayue, Yang, Yu, Lu, Tiantian, Ban, Fangfang, Hu, Xueqiong, Qian, Zhongji, Hong, Pengzhi, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608504/
https://www.ncbi.nlm.nih.gov/pubmed/37888437
http://dx.doi.org/10.3390/md21100502
_version_ 1785127795826884608
author Wang, Yawen
Zhou, Longjian
Chen, Minqi
Liu, Yayue
Yang, Yu
Lu, Tiantian
Ban, Fangfang
Hu, Xueqiong
Qian, Zhongji
Hong, Pengzhi
Zhang, Yi
author_facet Wang, Yawen
Zhou, Longjian
Chen, Minqi
Liu, Yayue
Yang, Yu
Lu, Tiantian
Ban, Fangfang
Hu, Xueqiong
Qian, Zhongji
Hong, Pengzhi
Zhang, Yi
author_sort Wang, Yawen
collection PubMed
description The prevalence of gout and the adverse effects of current synthetic anti-gout drugs call for new natural and effective xanthine oxidase (XOD) inhibitors to target this disease. Based on our previous finding that an edible seaweed Pterocladiella capillacea extract inhibits XOD, XOD-inhibitory and anti-inflammatory activities were used to evaluate the anti-gout potential of different P. capillacea extract fractions. Through affinity ultrafiltration coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS), feature-based molecular networking (FBMN), and database mining of multiple natural products, the extract’s bioactive components were traced and annotated. Through molecular docking and ADMET analysis, the possibility and drug-likeness of the annotated XOD inhibitors were predicted. The results showed that fractions F4, F6, F4-2, and F4-3 exhibited strong XOD inhibition activity, among which F4-3 reached an inhibition ratio of 77.96% ± 4.91% to XOD at a concentration of 0.14 mg/mL. In addition, the P. capillacea extract and fractions also displayed anti-inflammatory activity. Affinity ultrafiltration LC-MS/MS analysis and molecular networking showed that out of the 20 annotated compounds, 8 compounds have been previously directly or indirectly reported from seaweeds, and 4 compounds have been reported to exhibit anti-gout activity. Molecular docking and ADMET showed that six seaweed-derived compounds can dock with the XOD activity pocket and follow the Lipinski drug-like rule. These results support the value of further investigating P. capillacea as part of the development of anti-gout drugs or related functional foods.
format Online
Article
Text
id pubmed-10608504
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106085042023-10-28 Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction Wang, Yawen Zhou, Longjian Chen, Minqi Liu, Yayue Yang, Yu Lu, Tiantian Ban, Fangfang Hu, Xueqiong Qian, Zhongji Hong, Pengzhi Zhang, Yi Mar Drugs Article The prevalence of gout and the adverse effects of current synthetic anti-gout drugs call for new natural and effective xanthine oxidase (XOD) inhibitors to target this disease. Based on our previous finding that an edible seaweed Pterocladiella capillacea extract inhibits XOD, XOD-inhibitory and anti-inflammatory activities were used to evaluate the anti-gout potential of different P. capillacea extract fractions. Through affinity ultrafiltration coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS), feature-based molecular networking (FBMN), and database mining of multiple natural products, the extract’s bioactive components were traced and annotated. Through molecular docking and ADMET analysis, the possibility and drug-likeness of the annotated XOD inhibitors were predicted. The results showed that fractions F4, F6, F4-2, and F4-3 exhibited strong XOD inhibition activity, among which F4-3 reached an inhibition ratio of 77.96% ± 4.91% to XOD at a concentration of 0.14 mg/mL. In addition, the P. capillacea extract and fractions also displayed anti-inflammatory activity. Affinity ultrafiltration LC-MS/MS analysis and molecular networking showed that out of the 20 annotated compounds, 8 compounds have been previously directly or indirectly reported from seaweeds, and 4 compounds have been reported to exhibit anti-gout activity. Molecular docking and ADMET showed that six seaweed-derived compounds can dock with the XOD activity pocket and follow the Lipinski drug-like rule. These results support the value of further investigating P. capillacea as part of the development of anti-gout drugs or related functional foods. MDPI 2023-09-22 /pmc/articles/PMC10608504/ /pubmed/37888437 http://dx.doi.org/10.3390/md21100502 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Yawen
Zhou, Longjian
Chen, Minqi
Liu, Yayue
Yang, Yu
Lu, Tiantian
Ban, Fangfang
Hu, Xueqiong
Qian, Zhongji
Hong, Pengzhi
Zhang, Yi
Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction
title Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction
title_full Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction
title_fullStr Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction
title_full_unstemmed Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction
title_short Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction
title_sort mining xanthine oxidase inhibitors from an edible seaweed pterocladiella capillacea by using in vitro bioassays, affinity ultrafiltration lc-ms/ms, metabolomics tools, and in silico prediction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608504/
https://www.ncbi.nlm.nih.gov/pubmed/37888437
http://dx.doi.org/10.3390/md21100502
work_keys_str_mv AT wangyawen miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT zhoulongjian miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT chenminqi miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT liuyayue miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT yangyu miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT lutiantian miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT banfangfang miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT huxueqiong miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT qianzhongji miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT hongpengzhi miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction
AT zhangyi miningxanthineoxidaseinhibitorsfromanedibleseaweedpterocladiellacapillaceabyusinginvitrobioassaysaffinityultrafiltrationlcmsmsmetabolomicstoolsandinsilicoprediction